Abstract
Pathophysiological biomarker–based clinical development of lecanemab (BAN2401), anti–Aβ protofibril antibody
Full Text
Sign-in/Register to access full text options
Published version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Similar Papers
Paper Title
Journal
Date